Why do some cancer cells break away from a tumor and travel to distant parts of the body? A team of oncologists and engineers from the University of Michigan teamed up to help understand this crucial question.
A class of FDA-approved cancer drugs may be able to prevent problems with brain cell development associated with disorders including Down syndrome and Fragile X syndrome, researchers at the University of Michigan Life Sciences Institute have found.
A new urine-based test improved prostate cancer detection – including detecting more aggressive forms of prostate cancer – compared to traditional models based on prostate serum antigen, or PSA, levels, a new study finds.
Screening to identify Type 2 diabetes followed by early treatment could result in substantial health benefits, according to new research that combined large scale clinical observations and innovative computer modelling.
Today, 181 future health care leaders will graduate from the University of Michigan Medical School, one of the largest classes in the school’s history. Among the members of the 165th graduating class are the first U-M medical graduates to pursue a specific concentration during all four years of their training, through the Paths of Excellence program launched in 2011.
What’s the only thing worse than having a urinary catheter when you’re in the hospital? Having one and getting a urinary tract infection (UTI) – or worse – as a result. Now, a new detailed guide gives doctors and nurses information to help decide which hospital patients may benefit from a urinary catheter – and which ones don’t.
People with depression or bipolar disorder often feel their thinking ability has gotten “fuzzy”, or less sharp than before their symptoms began. Now, researchers have shown in a very large study that effect is indeed real – and rooted in brain activity differences that show up on advanced brain scans.
For any biotechnology company, getting the first product out of the lab and into patients in a clinical trial is a major milestone, and a cause for celebration. But not many of those companies get to celebrate on the campus where the idea for their product was born and first developed.
Nearly half of American hospitals aren’t taking key steps to prevent a kind of gut infection that kills nearly 30,000 people annually and sickens hundreds of thousands more – despite strong evidence that such steps work, according to a new study.
BCBSM and UMHS will collaborate with emergency physicians at participating hospitals across the state to develop best practices to improve the experience and outcomes of patients receiving care in emergency departments.
When a hospital patient’s heart stops, the drama starts, as doctors and nurses work furiously at resuscitation. Some hospitals allow family members to watch, while the majority do not. Now, a study has shown for the first time on a national scale that patients do just as well after a cardiac arrest either way.
Millions of times a year, UMHS teams test samples of tissue, blood and other bodily fluids for patients of all ages. The results can reveal risks or signs of disease -- or response to treatment -- and help make a major difference in doctors’ decisions. A new $160 million project will give U-M’s clinical testing teams the best possible facilities to work in. It will allow them to continue giving patients and doctors the high-quality test results they seek, faster and with higher reliability.
If you got hit with any of the ‘intestinal bugs’ that went around this winter, you’ve felt the effects of infectious microbes on your digestive system. But scientists don’t fully understand what’s going on in gut infections like that. Now, a new $6.4 million grant will fuel research based on stem cells to find out.
Three U-M professors, including a Medical School professor who specializes in the history of medicine, are among 175 winners of the Guggenheim Fellowships, which are awarded annually for distinguished achievement in the past and exceptional promise for future accomplishment.
Two young men in their late teens sit in adjacent rooms of an inner-city emergency room. One is getting care for injuries he suffered in a fight, the other, for a sore throat. A study finds that the one who had been in a fight will have a nearly 60 percent chance of becoming involved in a violent incident involving a firearm within the next two years.
What happens in the moments just before death is widely believed to be a slowdown of the body’s systems as the heart stops beating and blood flow ends. But there's a brainstorm happening, strongly synchronized with heart rhythm. Blocking this brain outflow may change the odds of survival for those who suffer cardiac arrest.
The little voice inside your head that tells you to eat, or stop eating, isn’t a little voice – it’s actually a cluster of about 10,000 specialized brain cells. And now, an international team of scientists has found tiny triggers inside those cells that give rise to this “voice”, and keep it speaking throughout life.
Most neurologists provide face-to-face care of neurology patients, many of whom require extensive evaluation and management. However, a new study finds face-to-face care by neurologists is severely undervalued by Medicare and reimbursed at a substantially lower rate than what Medicare pays doctors for performing tests and procedures.
One year ago, the first Michiganders gained health insurance coverage under the Healthy Michigan Plan, a unique form of Medicaid expansion tailored to the state’s residents. Now, more than 603,000 people have coverage under the plan -- and U-M researchers are hard at work to study how the new coverage affected them, their health care providers, and the state as a whole.
Researchers at the University of Michigan Comprehensive Cancer Center have developed a new drug candidate that shows potential in laboratory studies against a rare type of acute leukemia. And additional studies suggest the same compound could play a role in prostate cancer treatment as well.
An advanced form of life support that takes over for the failing hearts and lungs of critically ill patients saves lives. But for adults, the odds of surviving depend on which hospital provides the life-supporting treatment – with the best odds at ones that use the technique dozens of times a year, a new study finds.
Every day, patients around the country get IV devices placed in their arms, to make it easier to receive medicines or have blood drawn over the course of days or weeks. But these PICC lines, as they’re called, also raise the risk of potentially dangerous blood clots. Now, a U-M team has shown how serious that clot risk really is for hospitalized patients, and what factors put patients at highest risk.
While most of America worries about matchups on the basketball court, a different kind of match happened today at the U-M Medical School. And for the medical students involved, those who love them, and those who taught them, it was just as exciting as Selection Sunday.